Why Shares of uniQure Are Up Thursday
The company announced a reorganization that included layoffs.
Why Shares of uniQure Are Dropping Tuesday
The company is facing being delisted from the S&P 600 Index.
Why uniQure Stock Cratered This Week
An interim analysis for the company's Huntington's disease gene therapy wasn't a hit with investors.
Why uniQure Stock Is Crashing Today
Investors are focusing on the negative parts of the biotech company's interim results.
The S&P 500 Index ( $SPX ) ( SPY ) is up +0.09%, the Dow Jones Industrials Index ( $DOWI ) ( DIA ) is up +0.01%, and the Nasdaq 100 Index ( $IUXX ) ( QQQ ) is up +0.35%. U.S. stock index futures this morning...
First Gene Therapy for Hemophilia B, CSL's HEMGENIX®, Approved by the European Commission
/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) today announced that the European Commission has granted conditional marketing authorization (CMA)...